| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |